187 related articles for article (PubMed ID: 9462378)
1. Increased plasma levels of atrial natriuretic peptide and endocrine markers of volume depletion in patients with obstructive jaundice.
Gallardo JM; Padillo J; Martín-Malo A; Miño G; Pera C; Sitges-Serra A
Br J Surg; 1998 Jan; 85(1):28-31. PubMed ID: 9462378
[TBL] [Abstract][Full Text] [Related]
2. Randomized clinical trial of the effect of intravenous fluid administration on hormonal and renal dysfunction in patients with obstructive jaundice undergoing endoscopic drainage.
Padillo FJ; Briceño J; Cruz A; Chicano M; Naranjo A; Vallejo J; Martín-Malo A; Pera-Madrazo C; Sitges-Serra A
Br J Surg; 2005 Jan; 92(1):39-43. PubMed ID: 15521079
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of body fluid compartments and their relationship with water-electrolyte changes in obstructive jaundice].
Gallardo Valverde JM; Padillo Ruiz FJ; Rodríguez Quirós M; Gómez Alvarez M; Naranjo Rodríguez A; Martín Malo A; Puente Gutiérrez J; Miño Fugarolas G; Sitges-Serra A; Pera Madrazo C
Gastroenterol Hepatol; 1998 Jan; 21(1):1-5. PubMed ID: 9580150
[TBL] [Abstract][Full Text] [Related]
4. Multivariate analysis of factors associated with renal dysfunction in patients with obstructive jaundice.
Padillo FJ; Cruz A; Briceño J; Martin-Malo A; Pera-Madrazo C; Sitges-Serra A
Br J Surg; 2005 Nov; 92(11):1388-92. PubMed ID: 16078295
[TBL] [Abstract][Full Text] [Related]
5. Circulating bile is the main factor responsible for atrial natriuretic peptide release in experimental obstructive jaundice.
Martínez-Ródenas F; Pereira JA; Jiménez W; Gubern JM; Sitges-Serra A
Br J Surg; 1998 Apr; 85(4):480-4. PubMed ID: 9607527
[TBL] [Abstract][Full Text] [Related]
6. Renal function after dopamine and fluid administration in patients with malignant obstructive jaundice. A prospective randomized study.
Naranjo A; Cruz A; López P; Chicano M; Martín-Malo A; Sitges-Serra A; Muntané J; Padillo J
J Gastrointestin Liver Dis; 2011 Jun; 20(2):161-7. PubMed ID: 21725513
[TBL] [Abstract][Full Text] [Related]
7. Influence of erythropoietin treatment on plasma renin activity, aldosterone, vasopressin and atrial natriuretic peptide in haemodialyzed patients.
Kokot F; Wiecek A; Grzeszczak W; Klin M
Miner Electrolyte Metab; 1990; 16(1):25-9. PubMed ID: 2139159
[TBL] [Abstract][Full Text] [Related]
8. Fluid homeostasis after heart transplantation: the role of cardiac denervation.
Braith RW; Mills RM; Wilcox CS; Convertino VA; Davis GL; Limacher MC; Wood CE
J Heart Lung Transplant; 1996 Sep; 15(9):872-80. PubMed ID: 8889982
[TBL] [Abstract][Full Text] [Related]
9. Alterations of vasoconstrictor and sodium-regulating hormone systems in vascularly decompensated liver cirrhosis.
Tulassay T; Tulassay Z; Büki B; Szathmári M; Rascher W
Acta Med Hung; 1988; 45(1):73-81. PubMed ID: 2970621
[TBL] [Abstract][Full Text] [Related]
10. Atrial and brain natriuretic peptides as markers of cardiac load and volume retention in primary aldosteronism.
Kato J; Etoh T; Kitamura K; Eto T
Am J Hypertens; 2005 Mar; 18(3):354-7. PubMed ID: 15797653
[TBL] [Abstract][Full Text] [Related]
11. Influence of hemodialysis on the plasma levels of the atrial natriuretic factor in chronic renal failure.
Larochelle P; Béroniade V; Gutkowska J; Cusson JR; Lécrivain A; du Souich P; Cantin M; Genest J
Clin Invest Med; 1987 Jul; 10(4):350-4. PubMed ID: 2958203
[TBL] [Abstract][Full Text] [Related]
12. Hyponatremia of cirrhosis: role of vasopressin and decreased 'effective' plasma volume.
Akriviadis EA; Ervin MG; Cominelli F; Fisher DA; Reynolds TB
Scand J Gastroenterol; 1997 Aug; 32(8):829-34. PubMed ID: 9282977
[TBL] [Abstract][Full Text] [Related]
13. Decreased plasma brain natriuretic peptide levels after a successful maze procedure.
Watanabe M; Murakami M; Furukawa H; Nakahara H; Tanaka H; Sunamori M
J Heart Valve Dis; 2003 May; 12(3):287-91. PubMed ID: 12803326
[TBL] [Abstract][Full Text] [Related]
14. Changes in the pattern of visceral protein concentrations after internal biliary drainage in patients with obstructive jaundice.
Padillo FJ; Rodriguez M; Gallardo JM; Andicoberry B; Naranjo A; Minõ G; Sitges-Serra A; Pera-Madrazo C
Eur J Surg; 1999 Jun; 165(6):550-5. PubMed ID: 10433138
[TBL] [Abstract][Full Text] [Related]
15. Endocrine response to plasma volume expansion during the early postoperative period in heart transplant recipients.
Mertes PM; de Talancé N; Carteaux JP; Pinelli G; Dopff C; Burtin P; Villemot JP; Burlet C; Boulangé M
J Heart Lung Transplant; 1993; 12(6 Pt 1):1001-8. PubMed ID: 8312300
[TBL] [Abstract][Full Text] [Related]
16. Improved cardiac function in patients with obstructive jaundice after internal biliary drainage: hemodynamic and hormonal assessment.
Padillo J; Puente J; Gómez M; Dios F; Naranjo A; Vallejo JA; Miño G; Pera C; Sitges-Serra A
Ann Surg; 2001 Nov; 234(5):652-6. PubMed ID: 11685028
[TBL] [Abstract][Full Text] [Related]
17. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study.
Wozakowska-Kapłon B; Opolski G
Int J Cardiol; 2004 Aug; 96(2):171-6. PubMed ID: 15262030
[TBL] [Abstract][Full Text] [Related]
18. Effects of atrial natriuretic peptide at a low dose on water and electrolyte metabolism during general anesthesia.
Koda M; Sakamoto A; Ogawa R
J Clin Anesth; 2005 Feb; 17(1):3-7. PubMed ID: 15721722
[TBL] [Abstract][Full Text] [Related]
19. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
[TBL] [Abstract][Full Text] [Related]
20. Natriuretic peptides in patients with atrial fibrillation.
Wozakowska-Kapłon B; Opolski G; Herman Z; Kosior D
Cardiol J; 2008; 15(6):525-9. PubMed ID: 19039756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
